CTRI/2020/04/024756尚未招募4 期
TO COMPARE THE SAFETY & EFFICACY OF AZILSARTAN VERSUS OLMESARTAN AS ADD ON THERAPY TO CHLORTHALIDONE IN COEXISTING HYPERTENSION WITH TYPE-2 DIABETES MELLITUS RANDOMISED CONTROLLED TRIA
DR DEEKSHA SHARMA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Willing to give informed consent for the study.
- •Consenting adult patients of age > 18 yrs of either sex.
- •Ambulatory patients diagnosed with hypertension with type 2 diabetes mellitus who have blood pressure > 130/80 mmhg on chlorthalidone therapy
排除标准
- •Patients age less than 18 years.
- •Patients not willing to give written informed consent
- •Type 1 diabetes mellitus patients
- •Stage IV chronic kidney disease (GFRâ??<=â??30â??mL/min per 1.73â??m2)
- •Congestive heart failure NYHA classes II-IV.
- •Recent major cardiovascular events ( <6 months prior to randomization)
- •Pregnant and lactating females
- •Known hypersensitivity to drugs
研究者
相似试验
已完成
不适用
A clinical trial to study the effects of two drugs,Azilsartan and Losartan in patients with high blood pressureCTRI/2020/08/027209PIMS105
尚未招募
4 期
Effect of drug intervention on hypertensive patientsCTRI/2019/11/021961All India Institute of medical Sciences
已完成
不适用
Comparison of efficacy and safety of azilsartan and olmesartan in patients with essential hypertensioHypertensionJPRN-UMIN000016249Department of Cardiology, Fukuoka University School of Medicine60
招募中
不适用
Evaluation for Efficacy and Safety of Azilsartan in Patients with HypertensioEssential HypertensionJPRN-UMIN000008577Department of Medicine and Bioregulatory SciencesThe University of Tokushima, Graduate School of Health Biosciences30
已完成
不适用
Efficacy and safety of treatment with Azilsartan in type 2 diabetes mellitus patients with hypertension who did not show target blood pressure by telmisartan.Type 2 diabetes mellitus with hypertensionJPRN-UMIN000010604Iwasaki Naika Clinic20